It is a trading private limited company based in Delhi, Delhi, India, established in 2018.
2018 | Delhi, Delhi, India | ActiveDaikon Pharmaceuticals Private Limited, a active private limited company, was established on 08 March 2018 in Delhi, Delhi, India. Engaging in wholesale within the trade sector, it holds CIN: U74994DL2018PTC330537. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Amrit Kaushal (Managing Director), Menka Kumari (Director). It holds ₹4.90 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at E-16/1530, Plot No- 68, Bapa Nagar, Arya Samaj Road, Karol Bagh,, Delhi, Delhi, 110005.
U74994DL2018PTC330537
330537
08 March 2018
₹1.00 M
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Daikon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amrit Kaushal | Managing Director | 08 Mar 2018 | Current |
| Menka Kumari | Director | 08 Mar 2018 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Daikon Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 25.91% increase. The company also saw a substantial improvement in profitability, with a 68.64% increase in profit. The company's net worth Soared by an impressive increase of 38.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Daikon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹4,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 2024 | Others | ₹4.90 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Daikon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Daikon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daikon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Daikon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Daikon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 4.90 M with Charge ID 100972929 was registered on 04 Aug 2024. was documented.
The activity Amrit Kaushal was appointed as a Managing Director was appointed as a Managing Director on 08 Mar 2018 & has been associated with this company since 7 years 8 months . was completed.
Menka Kumari was appointed as a Director was appointed as a Director on 08 Mar 2018 & has been associated with this company since 7 years 8 months . was recorded as a recent event.
Progress on Daikon Pharmaceuticals Private Limited was registered on 08 Mar 2018 with Roc Delhi & aged 7 years 8 months as per MCA records. was documented.
The CIN of Daikon Pharmaceuticals Private Limited is U74994DL2018PTC330537.
Daikon Pharmaceuticals Private Limited is headquartered at E-16/1530, Plot No- 68, Bapa Nagar, Arya Samaj Road, Karol Bagh,, Delhi, Delhi, 110005.
Daikon Pharmaceuticals Private Limited was incorporated on 08 March 2018.
The current directors of Daikon Pharmaceuticals Private Limited are
The primary industry of Daikon Pharmaceuticals Private Limited is Trade.
Daikon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Daikon Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX